Home » Topics » BioWorld Science

BioWorld Science
RSS

5-HT1A agonist for cognition disorders disclosed

June 21, 1996

Alzheimer's beta-protein inhibition method described

June 21, 1996

Cholinergic agonists claimed by Lilly

June 21, 1996

Anergen's MS-AnergiX enters phase I for MS

June 21, 1996

Agents for multiple sclerosis disclosed

June 21, 1996

Discovery Therapeutic's N-0923 trial results to be presented

June 21, 1996

Peptides resembling h-MBP claimed

June 21, 1996

COMT inhibitor disclosed by Roche

June 21, 1996

BioKePharm and Gruppo Marcucci to merge

June 21, 1996

Taro's anticonvulsant drug undergoes development

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.